Moreover, the ratio between CD8+ cells and regulatory T cells (CD4+FoxP3+) in bone biopsies from osteosarcoma patients is important for discriminating between patients with an expected prolonged survival from those with a poor prognosis [60]. This evidence concerns the gene CD8A and osteosarcoma.